Japan OKs Insurance Coverage of Alzheimer’s Drug Lecanemab Injection
Tokyo, Nov. 6 (Jiji Press)–An advisory panel to Japan’s health minister approved Friday public health insurance coverage for an injection version of lecanemab, an Alzheimer’s medicine developed by Eisai Co. and Biogen Inc., and its administration at patients’ homes, effective on Nov.